Combination therapy to prevent DM2

September 2010
Internal Medicine Alert;9/29/2010 Clinical Briefs, p144
The article offers a news brief on the study of combined dose of low-dose metformin (500 mg bid) and low-dose rosiglitazone (2 mg qd) or placebo for the prevention of type 2 diabetes.


Related Articles

  • Are Diabetes Prevention Treatments Truly Disease Modifying?  // OB/GYN Clinical Alert;Aug2011 Clinical Briefs in Primary, p16 

    The article reports on the Diabetes Reduction Assessment Ramipril and Rosiglitazone Medication (DREAM) Trial, which examined the drugs ramipril and rosiglitazone and their impact on type 2 diabetes (DM2) prevention.

  • Combination of treatments 'can help prevent diabetes'.  // GP: General Practitioner;6/11/2010, p13 

    The article presents the findings of a research conducted on the effectiveness of combination therapy with rosiglitazone and metformin on patients with impaired glucose tolerance (IGT). The research reveals that the therapy half the maximum dose is highly effective in prevention of type-2...

  • HbA1c as a Predictor of Diabetes and as an Outcome in the Diabetes Prevention Program: A Randomized Clinical Trial. Knowler, William C. // Diabetes Care;Jan2015, Vol. 38 Issue 1, p51 

    OBJECTIVE Glycated hemoglobin (HbA1c), a standard measure of chronic glycemia for managing diabetes, has been proposed to diagnose diabetes and identify people at risk. The Diabetes Prevention Program (DPP) was a 3.2-year randomized clinical trial of preventing type 2 diabetes with a 10-year...

  • The New Diabetes Epidemic: What's Fueling It, How To Combat It.  // Environmental Nutrition;May2001, Vol. 24 Issue 5, p1 

    Provides tips on preventing type two diabetes in the United States. Link between obesity and diabetes; Complications of diabetes; Maintenance a health weight among diabetics; Necessity of physical activity; Monitor of blood sugar.

  • This alpha-glucosidase inhibitor improves glucose tolerance, lowers insulin levels.  // Modern Medicine;Oct94, Vol. 62 Issue 10, p26 

    Reports on a study conducted by Robert G. Josse which found that the alpha-glucosidase inhibitor acarbose may prevent impaired glucose tolerance from progressing to noninsulin-dependent diabetes mellitus. Use of acarbose as a monotherapy and an adjunct to other standard noninsulin-dependent...

  • Non-insulin dependent diabetes mellitus: The gathering storm. O'Rahilly, Stephen // BMJ: British Medical Journal (International Edition);03/29/97, Vol. 314 Issue 7085, p955 

    Explores the causes of the massive increase in the global prevalence of non-insulin dependent diabetes and the therapeutic tools to fight against the consequences of the epidemic. Widespread Westernization of dietary habits and patterns of physical activity; Identification of specific subtypes;...

  • What's Preventing Us from Preventing Type 2 Diabetes?  // New England Journal of Medicine;12/20/2012, Vol. 367 Issue 25, p2458 

    A correction to the article "What's Preventing Us From Preventing Type 2 Diabetes?" that was published in a 2012 issue of "The New England Journal of Medicine" is presented.

  • editor's note. diabetes solutions. Brechka, Nicole // Better Nutrition;Jun2012, Vol. 74 Issue 6, p6 

    The article reports on a global increase which has been seen in the incidence of type two diabetes and presents information on a report within the issue that discusses a diet and supplement plan for diabetics.

  • Go Green to Stop Diabetes.  // Prevention;Jan2011, Vol. 63 Issue 1, p37 

    The article emphasizes the significance of green vegetables in the prevention of type 2 diabetes.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics